Vera Therapeutics (VERA) Other Working Capital Changes (2020 - 2026)

Vera Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at -$182000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 103.1% year-over-year to -$182000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (down 147.3% YoY), and the FY2025 full-year result was $3.9 million, up 500.41% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$182000.0, down from $372000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $7.7 million in Q3 2022, with the low at -$6.7 million in Q2 2025.
• Historically, Other Working Capital Changes has averaged $488352.9 across 5 years, with a median of $303000.0 in 2022.
• The largest YoY upside for Other Working Capital Changes was 1398.98% in 2025 against a maximum downside of 1527.78% in 2025.
• Vera Therapeutics' Other Working Capital Changes stood at $482000.0 in 2022, then tumbled by 234.65% to -$649000.0 in 2023, then jumped by 238.21% to $897000.0 in 2024, then tumbled by 58.53% to $372000.0 in 2025, then tumbled by 148.92% to -$182000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$182000.0 (Q1 2026), $372000.0 (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.